Loading...
Market
Will Siemens Healthineers' stock price increase by more than 5% within one month of completing the acquisition of Novartis' Molecular Imaging Business?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Stock market data from financial platforms such as Yahoo Finance or Bloomberg
Story
Siemens Healthineers to Acquire Novartis' Molecular Imaging Business in $224 Million Deal
Aug 26, 2024, 12:36 PM
Siemens Healthineers has agreed to acquire a part of Novartis' business specializing in radioactive chemicals used for cancer scans. The $224 million deal involves the molecular imaging business for Fluorine-18 positron emission tomography (PET) scans. This acquisition is expected to further boost Siemens Healthineers' healthcare operations. Novartis confirmed receiving a binding offer from Siemens Healthineers for this acquisition.
View original story
Similar markets
Increase by more than 10% • 25%
Increase by up to 10% • 25%
No significant change • 25%
Decrease • 25%
Yes • 50%
No • 50%
Less than 5% • 25%
5% to 10% • 25%
10% to 15% • 25%
More than 15% • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%